Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsten M Timms

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Biomedicine & Biotechnology|August 14, 2010
Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridizationVictor Abkevich, Diana Iliev, Kirsten M Timms, et al.
European Urology Oncology|January 5, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer PatientsOlivier Cussenot, Kirsten M Timms, Emmanuel Perrot, et al.
JCO Precision Oncology|February 9, 2022
Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to ChemotherapySafi Shahda, Kirsten M Timms, Ashley A Ibrahim, et al.
Gynecologic Oncology|March 13, 2012
BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancerRebecca Byler Dann, Julie A DeLoia, Kirsten M Timms, et al.
Human Genetics|January 17, 2004
A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigreeKirsten M Timms, Susanne Wagner, Mark E Samuels, et al.
Cancers|January 21, 2023
Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous CarcinomaElizabeth A Bloom, Pamela N Peters, Regina Whitaker, et al.
British Journal of Cancer|October 16, 2018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerJai N Patel, Ioana Braicu, Kirsten M Timms, et al.
Genes, Chromosomes & Cancer|November 15, 2011
Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenograftsJurjen J Boonstra, Ronald van Marion, Hannie J C W Douben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
Tumor <i>BRCA1</i> Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy ResistanceAnosheh Afghahi, Kirsten M Timms, Shaveta Vinayak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Biomedicine & Biotechnology|August 14, 2010
Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridizationVictor Abkevich, Diana Iliev, Kirsten M Timms, et al.
European Urology Oncology|January 5, 2024
Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer PatientsOlivier Cussenot, Kirsten M Timms, Emmanuel Perrot, et al.
JCO Precision Oncology|February 9, 2022
Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to ChemotherapySafi Shahda, Kirsten M Timms, Ashley A Ibrahim, et al.
Gynecologic Oncology|March 13, 2012
BRCA1/2 mutations and expression: response to platinum chemotherapy in patients with advanced stage epithelial ovarian cancerRebecca Byler Dann, Julie A DeLoia, Kirsten M Timms, et al.
Human Genetics|January 17, 2004
A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigreeKirsten M Timms, Susanne Wagner, Mark E Samuels, et al.
Cancers|January 21, 2023
Association of Genomic Instability Score, Tumor Mutational Burden, and Tumor-Infiltrating Lymphocytes as Biomarkers in Uterine Serous CarcinomaElizabeth A Bloom, Pamela N Peters, Regina Whitaker, et al.
British Journal of Cancer|October 16, 2018
Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancerJai N Patel, Ioana Braicu, Kirsten M Timms, et al.
Genes, Chromosomes & Cancer|November 15, 2011
Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenograftsJurjen J Boonstra, Ronald van Marion, Hannie J C W Douben, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2017
Tumor <i>BRCA1</i> Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy ResistanceAnosheh Afghahi, Kirsten M Timms, Shaveta Vinayak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2016
Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast CancerMarie-Kristin von Wahlde, Kirsten M Timms, Anees Chagpar, et al.
Pageof 4